Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The SCORE-NMIBC study is a prospective, multi-center, study designed to collect data and biological samples from participants diagnosed with non-muscle Invasive Bladder Cancer (NMIBC). Study participants will undergo research blood and urine collections, as well as tumor tissue collected as part of a standard-of-care procedure(s), for use in research. Collected samples and data will be analyzed to evaluate biomarkers associated with development and validation of cancer monitoring and detection assays ("Natera cancer monitoring and detection test(s)").
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Diagnoza podejrzanego zaawansowanego raka pęcherza moczowego nieniszczącego mięśni
- •Kwalifikacja do leczenia lub operacji usunięcia pęcherza
- •Gotowość do pobrań krwi
- •Gotowość do zbierania próbek moczu
- •Zgoda na przekazanie tkanki guza do badań
- •Zdolność do spełnienia wymagań badania
✗ Disqualifies
- •Ciąża lub karmienie piersią
- •Leczenie innego raka w ciągu ostatniego roku
- •Aktywny nowotwór w innym miejscu ciała (z wyjątkiem usuniętego raka skóry)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 13, 2026
- Sex
- No restrictions
Locations (1)
Natera, Inc.
Austin, United States
Trial contact
SCORE-NMIBC Study team
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/14/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.